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Our willingness to take risks, our ability to wait or the speed with which to make decisions 
are central features of our personality. However, it is now recognized that impulsive and 
risk-taking behaviours are not a unitary construct, and different aspects can be both 
psychologically and neutrally dissociated. The range of neurochemicals and brain systems 
that govern these behaviours is extensive, and this may be a contributing factor to the 
phenotypic range seen in the human population. However, this variety can also be 
pathological as extremes in risk-taking and impulsive behaviours are characteristics of many 
neuropsychiatric and indeed neurodegenerative disorders. This spans obsessive–compulsive 
disorder, where behaviour becomes ridged and non-spontaneous, to the nonsensical risk-
taking seen in gambling and drug taking. This article is part of the theme issue ‘Risk taking 





. . .our impulses are too strong for our judgement sometimes  
                                                                                          – Thomas Hardy, Tess of the D’Urbervilles 
 
How we respond in the face of a changing social and/or non-social environment is 
fundamental to human personality, and is an important facet of all animal behaviour. 
Underpinning this response is our willingness to take risks, our ability to wait or the speed 
with which we make decisions. At face value, risk-taking behaviour and impulsive behaviour 
are one and the same. However, research over a number of decades has established not 
only that risk taking and impulsivity can be dissociated, in terms of delay discounting for 
example [1,2], but that impulsivity itself is not a unitary construct and that a number of 
distinct facets are behaviourally dissociable [3–5]. More recent research has demonstrated 
that these are not simply descriptive distinctions, as we now know that discrete aspects of 
impulsive behaviour are mediated by different brain circuitries and neurochemistries [6,7], 
and that variations in these different forms of impulsive behaviour often do not correlate 
[8]. Moreover, a large range of psychiatric disorders, spanning obsessive– compulsive 
disorder, where behaviour becomes ridged and non-spontaneous, to the nonsensical risk-
taking seen in gambling and drug taking, are classified as having an impulsive component. 
Yet, these too present with different patterns of impulsive behavioural abnormalities [9–
11], leading to distinct therapeutic strategies for different impulse control disorders [12]. 
 
Our aim, when compiling this Theme Issue, was to broadly explore impulsive and risk-taking 
behaviour. Collectively, the papers discuss the distinctions between discrete behaviours, the 
basic neural mechanisms and clinical conditions where abnormal risk-taking or impulsive 
behaviour is a feature. Additionally, a number of papers also consider the theories relating 
to how risk-taking and impulsive behaviour is generated within the brain, and how it may 
have developed over evolutionary time. Nevertheless, one aspect that is not covered 
specifically, in any great detail, in this Theme Issue is the genetic contribution to impulsive 
and risk-taking behaviours, despite the fact there are a great many studies linking single 
genes with aspects of impulsive behaviour and risk-taking. These include numerous rodent 
studies where the expression of a key candidate gene has been manipulated resulting in 
changes in impulsive and/or risk-taking behaviours [13–17], and even rare mutations in 
human families that link single genes to impulsive, risky or violent behaviour [18,19]. 
However, more general analyses of genetic variation and/or heritability are limited to a 
handful of rodent experiments [20–23] and twin studies in humans [24]. Moreover, 
convincing examples of hypothesis-free genome-wide studies of risk-taking and impulsive 
behaviour are limited. A recent genome-wide association study (GWAS) of delay discounting 
performance with 23 217 participants identified only one genome-wide significant single-
nucleotide polymorphism [25]. Although located in a convincing target associated with the 
serotonin system (GPM6B), this is obviously a disappointing return. 
 
The reason for this is probably because of the issue outlined above, and explored in greater 
detail by a number of papers in this special issue, which is that impulsivity and risk-taking 
behaviours represent many distinct constructs that interact in a number of complex ways. 
This is in contrast to simpler measures, such as height and body-mass index (BMI), in which 
GWAS studies have produced hundreds of genetic associations [26]. It is probably no 
surprise that the only really successful genome-wide study thus far has used an operational 
measure (delay discounting) rather than a broader definition of ‘choice impulsivity’ [25]. As 
a consequence, at present it is not possible to provide a cohesive and over-arching analysis 
of how genetic variation contributes to risk-taking and impulsive behaviours, in the same 
way that pathway analysis of GWAS data has generated novel insights into the biology of 
schizophrenia [27,28] and Alzheimer’s disease [29] for instance. 
 
2. Overview of theme issue 
 
As indicated above, this Theme Issue discusses many aspects of impulsive behaviour and 
risk-taking, bringing together basic researchers examining the mechanisms underpinning 
these behaviours, clinicians highlighting how these behaviours differentially impact on a 
range of conditions, and theorists discussing how brain systems may produce these 
behaviours and/or how they have developed over evolutionary time. Broadly the papers are 
grouped in this manner, although, of course, they all touch upon clinical conditions where 
impulsive or risk-taking behaviour goes awry. 
 
In the first paper, Rosenbaumet al. [30] provide an overview of risky and impulsive choice 
behaviour, with particular emphasis on how these change over the course of development 
and maturity. The next two papers form a pair, as both examine the conflict between choice 
of immediate but uncertain food rewards over delayed but certain food rewards. Stokes et 
al. [31] explore how this phenomenon varies in people in relation to BMI, and following 
exposure to food cues, such as food aroma. These findings have implications for behaviours 
that contribute to the rise in obesity in environments where food is readily available. Humby 
et al. [32] then describe the development of a touch-screen-based test of this same 
behaviour in mice. Using a behavioural pharmacology approach, they show that the choice 
of immediate but uncertain rewards in this task is sensitive to manipulations of 5HT2CR, a 
key receptor mediating the effects of serotonin on both impulse control [33–35], and 
appetite [36,37]. 
 
Also addressing the psychology of conflict over choices, Studer et al. [38] explore whether 
precommitment strategies can aid individuals to achieve effort-requiring goals. The authors 
used two tasks, one where the choice was between a zero effort, small reward option and 
an increasing effort, large reward option (effort task); and one where the choice was 
between an immediate small reward option and an increasingly delayed, large reward 
option (delay task). The precommitment strategy involved choosing to remove the zero-
effort or immediate reward option completely, and instead committing to the increasing 
effort, higher reward option in the effort task or the increasingly delayed, higher reward 
option in the delay task. In both the effort and delay tasks, where precommitment was 
chosen in trials, participants improved their rates of obtaining the larger reward. In addition, 
the authors used computational models of the choice behaviour to demonstrate that 
participants used precommitment to optimize their choice of the larger (but more effortful- 
or delayed-) reward by eliminating opportunity costs (i.e. as a self-motivational measure), 
rather than to prevent anticipated failures (i.e. as a self-regulatory measure). These data 
have obvious practical implications, and suggest the use of precommitment schemes in 
exercise and rehabilitation interventions. 
 
Dalley & Ersche [39] dig more deeply into the neurobiology of one aspect of impulsivity, 
namely waiting impulsivity. Reviewing both animal and human studies, they detail the brain 
systems and neurotransmitters involved in mediating the ability to withhold a prepotent 
response until required. In addition to focusing on the fundamental mechanisms, this article 
links nicely with the next grouping of papers, more focused on clinical aspects. Specifically, 
Dalley & Ersche argue the importance of waiting impulsivity as a dimensional trait 
determining the predisposition to disorders of incentive motivation, particularly drug 
addiction. Moreover, they highlight the role of the serotonin system in the development of 
compulsive drug taking. 
 
The relationship between impulsivity and drug addiction is explored further by Vassileva & 
Conrod [40] and Leeman et al. [41]. Vassileva focuses on how treatments could be directed 
at addressing domains of impulsivity as a novel clinical intervention for substance use 
disorders. Leeman et al. extend the role of impulsivity in addiction to include sexual 
tendencies in the light of the inclusion of compulsive sexual behaviour in the most recent 
edition of the International Classification of Diseases. Their systematic review supports the 
idea of a role for abnormal impulsivity as a precipitating factor or a consequence of 
addictive and/or sexual behaviours, but highlights gaps in the literature that need to 
be addressed with further, focused research. 
 
The next two review articles broaden the discussion of impulsivity and risk-taking in the 
clinical context to include psychiatric disorders more generally. Lijffijt et al. [42] specifically 
focus on suicidality in bipolar disorder. They argue that the interaction between premorbid 
impulsivity and behavioural sensitization (in this case, the failure to reduce arousal in 
response to salient stimuli) can lead to a progression of psychiatric disorders. Lopez-Guzman 
et al. [43] discuss the interaction between choice impulsivity, as measured by delay 
discounting, and risk aversion. Although behaviourally and neurally distinct, the authors 
discuss the mathematical relationship between these two constructs, and in particular how 
operational measures of choice impulsivity often fail to take account of attitude to risk. They 
argue that this relationship may change in a complex manner, but nevertheless be key to 
understanding measures of choice impulsivity across a range of psychiatric disorders. 
 
The remaining articles in this Theme Issue are more theoretical. Hertwig et al. [44] maintain 
that different approaches that have been developed to measure risk preference in 
behavioural sciences and economics have led to ‘gaps’ in our understanding of how stable 
risk preference is. They argue that the self-report measures, used in the behavioural 
sciences, show a higher degree of convergent validity and temporal stability than the 
behavioural measures typically used to study economic choice. Although possibly a 
controversial position, Hertwig et al. suggest that future research needs to address these 
gaps to test their predictive validity for economic and health consequences. Also 
approaching the topic of risk taking from an economic perspective, Bossaerts et al. [45] 
reason that current theories of decision-making, which model uncertainty about decision 
options using the tools of probability theory, may not be effective. They argue that in many 
situations, models, such as the Savage framework, are computationally intractable and, in 
situations in which computational complexity is high, ineffective in representing uncertainty. 
The authors conclude that new theories of decision-making, plausible from both a 
computational perspective and a biological perspective, are required from a scientific 
perspective and a public policy perspective. 
 
The final two papers place impulsive behaviour and risk-taking in an evolutionary context. 
Hayden [46] takes a wide-ranging look at the issue of why impulsive and riskbased decisions 
appear to be sub-optimal (i.e. that choices do not maximize economical potential). 
Reasoning that the neural origins of self-control are primarily cognitive, Hayden also 
suggests that a more objective view tells us that although suboptimal choice is, on the face 
of it, a flaw, it is universal and is the product (or by-product?) of success over evolutionary 
time, therefore presumably is optimal in terms of biological function. Wilkins and 
Bhattacharya provide the theoretical basis for one possible contributing factor to why 
humans and animals may not appear optimal in their risk-taking and impulsive choices. 
Here, however, the focus is not on the psychological or behavioural level, but at the level of 
the gene. Specifically, they argue that the difference in reproductive variance between 
males and females—in many populations, male reproductive success is limited by access to 
females, whereas female reproductive success is mainly limited by physiology—can lead to 
differences in the ‘willingness’ of genes to be exposed to risk in the next generation. In 
particular, this has connotations for imprinted genes, a sub-set of mammalian genes that 
are differentially marked in a parent-of-origin-specific manner leading to monoallelic 
expression from one parental copy of the gene only. In the population scenario described 
above, the suggestion is that paternally expressed imprinted genes would broadly act to 
reduce risk-taking, whereas maternally expressed imprinted genes would be more tolerant 
of risk-taking due to their exposure to different rates of the reproductive variance in the 
previous generation. Indeed, recent work examining knockout mouse models of two 
imprinted genes, Nesp and Grb10, provides broad empirical support for this idea [13,14]. It 
is easy to see how such a genetic tug-of-war may produce impulsive or risk-taking behaviour 




Our aim is that the wide-ranging articles in this issue place our current understanding of 
risk-taking and impulsive behaviours in context. Nevertheless, what is abundantly clear is 
that there is still much work to be done in this field, at all levels of understanding. However, 
in bringing together a collection of papers that touch upon the basic and clinical science, 
and theoretical ideas, we hope this special issue will stimulate more research, but 
particularly cross-discipline research, into risk-taking and impulsive behaviours. 
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